MARKET

LUCD

LUCD

Lucid Diagnostics Inc.
NASDAQ
0.8057
-0.0203
-2.46%
After Hours: 0.8260 +0.0203 +2.52% 19:30 09/28 EDT
OPEN
0.8200
PREV CLOSE
0.8260
HIGH
0.8268
LOW
0.8026
VOLUME
786.37K
TURNOVER
--
52 WEEK HIGH
1.629
52 WEEK LOW
0.7500
MARKET CAP
163.75M
P/E (TTM)
-1.7179
1D
5D
1M
3M
1Y
5Y
1D
Analyst Reiterates Buy on Lucid Diagnostics as Medicare, Coding Tailwinds Support EsoGuard; $2 Price Target Maintained
TipRanks · 5d ago
Lucid Diagnostics advances Medicare reimbursement and coding infrastructure
TipRanks · 6d ago
Weekly Report: what happened at LUCD last week (0914-0918)?
Weekly Report · 09/21 09:30
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 09/18 12:06
Weekly Report: what happened at LUCD last week (0907-0911)?
Weekly Report · 09/14 09:32
Weekly Report: what happened at LUCD last week (0831-0904)?
Weekly Report · 09/07 09:30
Weekly Report: what happened at LUCD last week (0824-0828)?
Weekly Report · 08/31 09:32
Lucid Diagnostics Is Maintained at Buy by Ascendiant Capital
Dow Jones · 08/27 11:52
More
About LUCD
Lucid Diagnostics Inc. is a commercial-stage cancer prevention medical diagnostics company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company's products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. The Company is a subsidiary of PAVmed Inc.

Webull offers Lucid Diagnostics Inc stock information, including NASDAQ: LUCD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUCD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUCD stock methods without spending real money on the virtual paper trading platform.